[Irritable bowel syndrome: diagnostic criteria and recent advancement of its pharmacological management].
Matsueda
K
K
Division of Gastroenterology, National Center of Neurology and Psychiatry, Kohnodai Hospital.
D000180:Acrylic Resins / Q000627:therapeutic use; D002243:Carbolines / Q000627:therapeutic use; D003109:Colonic Diseases, Functional / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*
D000180:Acrylic Resins; D002243:Carbolines; D005765:Gastrointestinal Agents; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; C090840:alosetron; C030312:calcium polycarbophil